Shuhei Teranishi, Yuichi Ozawa, Yasuhiro Koh, Kazushige Wakuda, Yasutaka Watanabe, Ryotaro Morinaga, Akihiro Tamiya, Tomoki Aiba, Kohei Yoshimine, Daisuke Hazama, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Tetsunari Hase, Eiki Ichihara, Shuji Murakami, Mitsuo Osuga, Mototsugu Shimokawa, Hirotsugu Kenmotsu, Nobuyuki Yamamoto. "Brigatinib after lorlatinib and/or chemotherapy following first-line alectinib in ALK-rearranged NSCLC: Cohort B of the WJOG11919L/ABRAID study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.8606